Member Info for TorquayFan

Like others I bemoan the loss (for now?) of Inan from this BB. A plan to make both BB's better - if Inan would permanently filter Loz, Ruck/Gazza and Tosh on ADVFN, he can post there without the bile and flak - then it's easy to copy some of his thoughts/points in a calmer style.

Ray I saw your post about Inan - may I take it further ? When you started posting here a couple of years ago (?), I watched with admiration as Inan carefully coached you as you made very genuine efforts to develop your own grip on the 'Science'. For me that's testament to how kind Inan can be.

Moving on, we still have Burble, Bermuda, Ivy, Ray.P, WF, Crumbs, Konar and many others able to make Science/Patent inputs and many thanks to them as always.

Anyway, today, we have the Annual Report to play with.

(C7 for the record I have you back on screen. ATB)

Thanks for this yesterday. A quiet, balanced and comprehensive discussion. The UK Govt. (they were not alone), spent many months dissing the idea - what has that cost in lives and future tax rises ? As for 'freedom', it's rightly pointed out that it's the virus that takes the 'freedom' away ! I'd add that one persons 'freedom' not to wear, is likely to be another person's oppression by virus.

http://nautil.us/issue/90/something-green/the-importance-of-face-masks-and-the-tragedy-of-downplaying-them

Crumbs - crikey you get up early ! With respect there's more to it than, 'that is it'. Try this - filter Loz and the 'quicksand' and you'll see a really good discussion yesterday. Many good contributors. Never mind.

Inan's GBP 8 would be fine for me LOL. Tomorrow please. GLA

As an LSE poster for 9 years, (6817 posts), I'd venture to refer Members here if I may, to an excellent discussion yesterday between NXC and other Posters, about the Redmile saga on ADVFN, (TF 1014 posts).

NXC, Empty, Gooosed, Bermuda, Ivy, Supernumary, Goy and even ONW chipping in. Very interesting indeed.

Ivy and Gazza - you know my opinion that Inan always helps this LSE BB with the science and we owe him thanks for that. On balance, Inan's contribution is positive (IMO) and many are reliant on him and others for the science insights and most would not have wished to be without Inan over the years, (quicksands excepted LOL).

Contrary to Folklore here, ADVFN has it's real moments of interest and at times, a discussion that IMO, is well worth seeing. GLA

It'd be interesting to get some comments on this from EE :-

"Regional news tonight in the East reports genome research in UEA Norwich. To my surprise the UEA reports 100 different Covid19 variants IN NORFOLK ALONE. All samples tested appear to originate from the French/Italian strains, rather than Asian. I would have thought that might have implications for those working on vaccines that are highly-specific to the genome identified back in January?"

Again 13.20 / 32941 - David Evans . . . .

"My view on a Nasdaq listing is that discussion of the move is premature - I am not doubting the intent but a) SCLP has to achieve something tangible to warrant such a move and b)there would need to be a significant change in infrastructure to support such an undertaking and c) you would really only be making the move if one needed to raise a significant amount of capital ($100m+). We are two years away at least from a Nasdaq listing if that is the intent."

RW 12.24. To make it clear - I know you refer to Loz under the NXC heading, but new posters don't.

NXC - 9.5 million shares - good on him. Hope he's keeping well.

For any newbies, David Evans our ex-Chairman is NXC - from ADVFN . . .

"Whilst I was surprised by the timing of yesterday's news overall it is positive for Scancell Shareholders - Bermuda has provided an analysis of Redmile and their approach which should give Shareholders comfort. For my part I will be taking up the Open Offer re my holding of approx 9.5m shares and will continue to support the Company going forward."

OK Douve that's a good answer ! Time will tell if something of a 'deal' on a different angle or elsewhere appears. ATB

Meantime - you've heard no doubt of the Patient with a confirmed CV-19 re-infection, in the USA. BTW it's NOT Pres. Trump ! https://seekingalpha.com/news/3621570-first-case-of-covidminus-19-reinfection-confirmed-in-u-s?

OK Douve that's a good answer ! Time will tell if something of a 'deal' on a different angle or elsewhere appears. ATB

Meantime - you've heard no doubt of the Patient with a confirmed CV-19 re-infection, in the USA. BTW it's NOT Pres. Trump ! https://seekingalpha.com/news/3621570-first-case-of-covidminus-19-reinfection-confirmed-in-u-s?

Hi Douve - your 01.35 :-

This GBP 30 million might facilitate a rerate of the present Mcap, say via a Nasdaq listing, in which case, it'd be better than a GBP2 million deal would it not? Whatever transpires, I'm sure Redmile and Vulpes will ensure the nest egg is put to good use.

You post - "The latter also unfortunately suggests a commercial deal has again been kicked into the long grass". I've been arguing against that - the Redmile finance and ongoing commercial discussions may be in parallel. And, 'its very easy to jump to conclusions', which with respect, you have just done.

But good to see the other side of the discussion and ATB

Crumbs - Scancell can move towards a Nasdaq listing now ? IMO a good investment. When you look at BNTX Mcap now, where would Scancell be ? GNA (BTW 99% thumbs up for this news today).

Agree with that Botski ! The 'deal' front is nothing to do with this 'financing'. In your words, 'a red herring'. Douve - in this case Scancell have exceeded their case on timelines - finance wise. Why diminish that ?

Crumbs - 'we don't know anything about that that do we ?'

I don't see this funding as indicating or signifying the failure of any talks or as any sort of emergency bridging . . . .

ATB

Ivy - thanks. Coming back to this - "I don't see this funding as signifying the failure of any talks".

So those nursing hopes for an imminent announcement may still soon be vindicated - (that's 'may'). Tomorrow would be good Cliff if you've nothing else to do LOL. GLA

IMO that's terrific news indeed.

Quoted from the RNS - " Cancer Research UK (CRUK) are currently funding and sponsoring a Phase 1/2 trial with the Company's SCIB2 ImmunoBody® therapy and immune checkpoint inhibitor to target solid tumours. However in light of severe funding pressures, CRUK are currently reviewing their ability to continue to support their broad range of programmes."

Hooray - let's go now with our SCIB2 Scancell !

A few posters have mentioned this point - but we don't know anything about that that do we ?

Maybe the 'deals' discussions ARE going OK - if a deal should go through, a GBP 60 million nest egg (?) would be all the better would it not ? So I don't see this funding as signifying the failure of any talks or as any sort of emergency bridging . . . .

Pretty much unadulterated good news for me, (apart from creeping 'D' LOL) and very much an indicator that in the last few months, Scancell have undergone a major 'step function' in their realm of activity.

It's getting exciting now. GLA

Botski. Just noticed that. Naughty ! Keep the faith. GLA

Thanks. Great to know. ATB

C7 Inan is fine. Busy on other stuff.